{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/glatiramer-acetate.json","peptide":{"slug":"glatiramer-acetate","name":"Glatiramer acetate","url":"https://peptidescanner.com/peptides/glatiramer-acetate/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":65,"entries":[{"objectId":"story:clinicaltrials-gov-nct05344469-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-17","title":"ClinicalTrials.gov record NCT05344469","domain":"Clinical trials","dateInSource":"2026-11-16","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05344469-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct05344469-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct05344469-glatiramer-acetate-v1","contentSha256":"31e200eddb37851505c0601ffdc483911fde69dd2676e4dd2ecfd5956f54680b"},{"objectId":"story:fda-drugs-anda090218:v1","state":"current","stateChangedAt":"2026-11-17","title":"Drugs@FDA application ANDA090218","domain":"Regulatory","dateInSource":"2015-04-16","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda090218/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda090218-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#fda-drugs-anda090218-v1","contentSha256":"3f0f6212a6b2b019702c3f0cbc166314a5b4ffcf1598b1f36071cbd197b0c578"},{"objectId":"story:fda-drugs-anda091646:v1","state":"current","stateChangedAt":"2026-11-17","title":"Drugs@FDA application ANDA091646","domain":"Regulatory","dateInSource":"2017-10-03","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda091646/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda091646-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#fda-drugs-anda091646-v1","contentSha256":"095544c859347693dd909466e5cae7d40d987afb2c1e5c37268c27cf5fd3bf80"},{"objectId":"story:fda-drugs-anda203857:v1","state":"current","stateChangedAt":"2026-11-17","title":"Drugs@FDA application ANDA203857","domain":"Regulatory","dateInSource":"2024-09-25","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda203857/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda203857-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#fda-drugs-anda203857-v1","contentSha256":"6e90dae9faeda1a1f98a6002a8447c386e74c69f3d8a3691e1cf85067e626e1f"},{"objectId":"story:fda-drugs-anda206873:v1","state":"current","stateChangedAt":"2026-11-17","title":"Drugs@FDA application ANDA206873","domain":"Regulatory","dateInSource":"2024-09-25","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda206873/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda206873-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#fda-drugs-anda206873-v1","contentSha256":"59783360799097c93f9ef42a2d5cf3849cbdf82ab944fd52ed363ad69fec9efd"},{"objectId":"story:fda-drugs-anda206921:v1","state":"current","stateChangedAt":"2026-11-17","title":"Drugs@FDA application ANDA206921","domain":"Regulatory","dateInSource":"2018-02-12","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda206921/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda206921-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#fda-drugs-anda206921-v1","contentSha256":"250499ef3356e7c7130654d92608f8ef31a2d329e0ee7187ea7eb9f040a2f1a2"},{"objectId":"story:fda-drugs-anda206936:v1","state":"current","stateChangedAt":"2026-11-17","title":"Drugs@FDA application ANDA206936","domain":"Regulatory","dateInSource":"2017-10-03","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda206936/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda206936-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#fda-drugs-anda206936-v1","contentSha256":"fd3acc72cfbf5c1eca9150d4340cc85002d2fd1d5a22c9f57bc7101ca58d78ad"},{"objectId":"story:fda-drugs-anda208468:v1","state":"current","stateChangedAt":"2026-11-17","title":"Drugs@FDA application ANDA208468","domain":"Regulatory","dateInSource":"2025-05-07","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda208468/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda208468-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#fda-drugs-anda208468-v1","contentSha256":"573f0f88aedfa9bd82f893301861cf8487cfaa01edecd16f479d460547096173"},{"objectId":"story:fda-drugs-anda213382:v1","state":"current","stateChangedAt":"2026-11-17","title":"Drugs@FDA application ANDA213382","domain":"Regulatory","dateInSource":"2026-02-11","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda213382/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda213382-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#fda-drugs-anda213382-v1","contentSha256":"6bc5136c69690b171f58b53ee422ad52d3ac9377f55319a7d51f25fd62c2c7a7"},{"objectId":"story:fda-drugs-anda214022:v1","state":"current","stateChangedAt":"2026-11-17","title":"Drugs@FDA application ANDA214022","domain":"Regulatory","dateInSource":"2026-02-11","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda214022/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda214022-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#fda-drugs-anda214022-v1","contentSha256":"7940f7b7a08208c11a478a60426b680bf7c4b0a708ab65ed3ecd9c1316b2717a"},{"objectId":"story:fda-drugs-anda214741:v1","state":"current","stateChangedAt":"2026-11-17","title":"Drugs@FDA application ANDA214741","domain":"Regulatory","dateInSource":"2025-12-31","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda214741/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda214741-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#fda-drugs-anda214741-v1","contentSha256":"532b7c6c9226473d0479f5f7b014fc6f0ccf997a448c7fb9ea632b0cf04f97e4"},{"objectId":"story:fda-drugs-nda020622:v1","state":"current","stateChangedAt":"2026-11-17","title":"Drugs@FDA application NDA020622","domain":"Regulatory","dateInSource":"1996-12-20","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda020622/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-nda020622-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#fda-drugs-nda020622-v1","contentSha256":"996d2f0b52bc0bbc6cd6c39384f3781288910ea4a0abc33e12f514dee9c82520"},{"objectId":"story:federal-register-2015-32246:v1","state":"current","stateChangedAt":"2026-11-17","title":"Federal Register proposed rule 2015-32246","domain":"Regulatory","dateInSource":"2015-12-23","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/federal-register-2015-32246/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#federal-register-2015-32246-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#federal-register-2015-32246-v1","contentSha256":"c59248ccd44b2a4ff5ae8389a3d92eda75d391c86f96884c4255497ebd3266dd"},{"objectId":"story:federal-register-2016-08682:v1","state":"current","stateChangedAt":"2026-11-17","title":"Federal Register notice 2016-08682","domain":"Regulatory","dateInSource":"2016-04-15","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/federal-register-2016-08682/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#federal-register-2016-08682-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#federal-register-2016-08682-v1","contentSha256":"dbebf1252eee75f48888b712e86ed395caab46d1ea47116049fc8bcce5522d88"},{"objectId":"story:federal-register-2018-15735:v1","state":"current","stateChangedAt":"2026-11-17","title":"Federal Register notice 2018-15735","domain":"Regulatory","dateInSource":"2018-07-23","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/federal-register-2018-15735/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#federal-register-2018-15735-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#federal-register-2018-15735-v1","contentSha256":"732ae2af472a413dd766737ba099812816f1e019a1d79dec8b8bbf5c0bce736f"},{"objectId":"story:clinicaltrials-gov-nct00078338-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00078338","domain":"Clinical trials","dateInSource":"2018-06-27","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00078338-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00078338-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00078338-glatiramer-acetate-v1","contentSha256":"797e0b50074751ad7c8405e531e7013a3978e97352471399884f86aeeee3506b"},{"objectId":"story:clinicaltrials-gov-nct00176592-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00176592","domain":"Clinical trials","dateInSource":"2021-11-16","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00176592-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00176592-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00176592-glatiramer-acetate-v1","contentSha256":"27a5d3a2753d01310dfc61cc4d2cf1a50fbd82d7b5cc7b298e7edafc5523947d"},{"objectId":"story:clinicaltrials-gov-nct00203021-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00203021","domain":"Clinical trials","dateInSource":"2020-02-18","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00203021-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00203021-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00203021-glatiramer-acetate-v1","contentSha256":"d5a21c0f0e29e4de6ffa2cde950a857df5f59a47686d51670029dcefcc8385e6"},{"objectId":"story:clinicaltrials-gov-nct00211887-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00211887","domain":"Clinical trials","dateInSource":"2014-04-03","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00211887-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00211887-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00211887-glatiramer-acetate-v1","contentSha256":"d84c1c5878b1c1f31ebfa8f633704bdd529b273b06b409091b5bf1d5fce2cdef"},{"objectId":"story:clinicaltrials-gov-nct00239993-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00239993","domain":"Clinical trials","dateInSource":"2017-02-06","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00239993-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00239993-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00239993-glatiramer-acetate-v1","contentSha256":"49c74ee474a0aea0159cdc735175d48b1774847e0b0ddb7801cfb91fac360cc0"},{"objectId":"story:clinicaltrials-gov-nct00337779-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00337779","domain":"Clinical trials","dateInSource":"2011-10-10","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00337779-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00337779-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00337779-glatiramer-acetate-v1","contentSha256":"5a559b55bb37ea6ace69ae161fde4a4fbd6a138ee6283217648548265c8a3d1e"},{"objectId":"story:clinicaltrials-gov-nct00451204-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00451204","domain":"Clinical trials","dateInSource":"2016-06-16","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00451204-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00451204-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00451204-glatiramer-acetate-v1","contentSha256":"2341e75e5bf8b471c8cbabd975314b3113cca71dce36211d28f222a1cac3ec4a"},{"objectId":"story:clinicaltrials-gov-nct00451451-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00451451","domain":"Clinical trials","dateInSource":"2015-01-26","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00451451-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00451451-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00451451-glatiramer-acetate-v1","contentSha256":"3529a3b6d0645e9d90bd4461ba8b4d00b5cc69fc14f1b5b45af30a384d7df9d1"},{"objectId":"story:clinicaltrials-gov-nct00475865-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00475865","domain":"Clinical trials","dateInSource":"2012-11-06","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00475865-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00475865-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00475865-glatiramer-acetate-v1","contentSha256":"4208a65640940e08d171e2153e32cf91e4e92c284b4f993a4cf3561a8ee3aab3"},{"objectId":"story:clinicaltrials-gov-nct00666224-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00666224","domain":"Clinical trials","dateInSource":"2012-06-25","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00666224-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00666224-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00666224-glatiramer-acetate-v1","contentSha256":"1ea80ddf788d2f501575d26172b56ac82f207590bee32c8c710e95631fdc8341"},{"objectId":"story:clinicaltrials-gov-nct00811395-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00811395","domain":"Clinical trials","dateInSource":"2012-12-31","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00811395-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00811395-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00811395-glatiramer-acetate-v1","contentSha256":"2eea3afa6c5b24908e250fa49fe31965ae0822e2cd62363833574278b79f267d"},{"objectId":"story:clinicaltrials-gov-nct00856635-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00856635","domain":"Clinical trials","dateInSource":"2018-02-06","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00856635-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00856635-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00856635-glatiramer-acetate-v1","contentSha256":"62cbef92769d4fef364091d2850312128146814a2f660988c41e115682a29231"},{"objectId":"story:clinicaltrials-gov-nct00937157-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00937157","domain":"Clinical trials","dateInSource":"2021-03-19","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00937157-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00937157-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00937157-glatiramer-acetate-v1","contentSha256":"41a1fbfdc641bbe1cf227dde92a3981c52282304fb09002177e4af05e1c282d7"},{"objectId":"story:clinicaltrials-gov-nct00947752-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00947752","domain":"Clinical trials","dateInSource":"2017-03-14","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00947752-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00947752-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct00947752-glatiramer-acetate-v1","contentSha256":"8a23b965e8e3fe9ee8648a2ec902905df925d192a345c0351edff299374b142f"},{"objectId":"story:clinicaltrials-gov-nct01067521-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01067521","domain":"Clinical trials","dateInSource":"2021-12-09","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01067521-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01067521-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct01067521-glatiramer-acetate-v1","contentSha256":"0438eeaaca1052a2a0503d8b5db97bc4ef2ff89116a19640fda506c11db88442"},{"objectId":"story:clinicaltrials-gov-nct01071083-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01071083","domain":"Clinical trials","dateInSource":"2013-09-19","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01071083-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01071083-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct01071083-glatiramer-acetate-v1","contentSha256":"e43628f93b6f97c580945000de7e9bf036ee5913823023e6fba3bbfbf52e78fd"},{"objectId":"story:clinicaltrials-gov-nct01167426-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01167426","domain":"Clinical trials","dateInSource":"2013-10-17","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01167426-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01167426-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct01167426-glatiramer-acetate-v1","contentSha256":"22ed5b881333893d17e6090d486cb9fbc237b11be94422e5ce33bd87b9a5ba73"},{"objectId":"story:clinicaltrials-gov-nct01216072-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01216072","domain":"Clinical trials","dateInSource":"2014-02-10","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01216072-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01216072-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct01216072-glatiramer-acetate-v1","contentSha256":"25ce8459e53b2ae23d0ce6229058956d44bf81c7c2dec138e1138c99f597f55a"},{"objectId":"story:clinicaltrials-gov-nct01317004-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01317004","domain":"Clinical trials","dateInSource":"2015-06-22","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01317004-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01317004-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct01317004-glatiramer-acetate-v1","contentSha256":"1c1e833f1db66483a7718df7cb1dd59a756165609cc3a5f9817a2ff1e3af9510"},{"objectId":"story:clinicaltrials-gov-nct01534182-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01534182","domain":"Clinical trials","dateInSource":"2014-08-08","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01534182-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01534182-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct01534182-glatiramer-acetate-v1","contentSha256":"f18f22fd0cd105577721640a2dddfd04ba9b0fd41427c873daa21c70d3a23d2a"},{"objectId":"story:clinicaltrials-gov-nct01569451-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01569451","domain":"Clinical trials","dateInSource":"2018-06-08","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01569451-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01569451-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct01569451-glatiramer-acetate-v1","contentSha256":"9825f16ba33cc9ce5e2eb21ff06557ed554cc102bca7f688d0c5bfaa6107e64c"},{"objectId":"story:clinicaltrials-gov-nct01874145-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01874145","domain":"Clinical trials","dateInSource":"2016-01-14","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01874145-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01874145-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct01874145-glatiramer-acetate-v1","contentSha256":"c62924a919d34b84e6cadd98c54aa435d2b1607595586264f401b6ca76ca0c63"},{"objectId":"story:clinicaltrials-gov-nct02153723-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02153723","domain":"Clinical trials","dateInSource":"2018-11-05","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02153723-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct02153723-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct02153723-glatiramer-acetate-v1","contentSha256":"55e15c6f962fc0d35469400d66646bb8a0019cc0dba6c616a096ca9785c99881"},{"objectId":"story:clinicaltrials-gov-nct02499900-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02499900","domain":"Clinical trials","dateInSource":"2021-12-09","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02499900-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct02499900-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct02499900-glatiramer-acetate-v1","contentSha256":"c2c26b40294f76df939708943ee86b0fb643b5ebbe81b56a9defd00b94ecc23c"},{"objectId":"story:clinicaltrials-gov-nct03193866-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT03193866","domain":"Clinical trials","dateInSource":"2025-04-20","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03193866-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct03193866-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#clinicaltrials-gov-nct03193866-glatiramer-acetate-v1","contentSha256":"4a03cb26a41f0c3ccb93e1ea7aac038c13331fa83db2552b328e4c07043061d7"},{"objectId":"story:pubmed-pmid-22449210-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.","domain":"Literature metadata","dateInSource":"2015-11-19","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-22449210-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-22449210-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-22449210-glatiramer-acetate-v1","contentSha256":"a15b38130430cdd6a7ca1b95dde8d6dd521c51fa6abd46fc05d8f8c873942a0d"},{"objectId":"story:pubmed-pmid-22989378-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.","domain":"Literature metadata","dateInSource":"2022-04-08","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-22989378-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-22989378-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-22989378-glatiramer-acetate-v1","contentSha256":"54bbe01d636a639c6188d9f03c2c585724965f624acf595c8fdbec833642b3ac"},{"objectId":"story:pubmed-pmid-23203082-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?","domain":"Literature metadata","dateInSource":"2024-05-05","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23203082-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-23203082-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-23203082-glatiramer-acetate-v1","contentSha256":"aacc4ade8bc020097c73bd06b900f9bb2062759fdca8d26eb8da1395fb10b332"},{"objectId":"story:pubmed-pmid-23264098-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Interferon beta and glatiramer acetate therapy.","domain":"Literature metadata","dateInSource":"2024-02-04","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23264098-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-23264098-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-23264098-glatiramer-acetate-v1","contentSha256":"6b5a210e561f6302960e3c0eb45964069e5c14aaefbf87c0b880cd1c9d3a00b2"},{"objectId":"story:pubmed-pmid-23424159-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Randomized study combining interferon and glatiramer acetate in multiple sclerosis.","domain":"Literature metadata","dateInSource":"2026-05-18","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23424159-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-23424159-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-23424159-glatiramer-acetate-v1","contentSha256":"b0e17ff7024859747195a3a9eec15746dc5c94b29ed28d3d5c28ed82f3f748b1"},{"objectId":"story:pubmed-pmid-23589190-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.","domain":"Literature metadata","dateInSource":"2021-10-21","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23589190-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-23589190-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-23589190-glatiramer-acetate-v1","contentSha256":"a362470f033a60bccf2b27f288e3c70011016e6e98a699fb6f1d7c850a5346c8"},{"objectId":"story:pubmed-pmid-23709209-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"The use of interferon Beta and glatiramer acetate in multiple sclerosis.","domain":"Literature metadata","dateInSource":"2015-11-19","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23709209-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-23709209-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-23709209-glatiramer-acetate-v1","contentSha256":"c980b9171730ae797662032e358d89a3abe9ceec233ab15d575a075a4729729b"},{"objectId":"story:pubmed-pmid-23795716-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment.","domain":"Literature metadata","dateInSource":"2022-04-08","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23795716-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-23795716-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-23795716-glatiramer-acetate-v1","contentSha256":"0ce3c5f3ee7be668da5b2a6ce1b03d4ea114e31d3c19bf71eca9793b535c82c9"},{"objectId":"story:pubmed-pmid-25062935-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.","domain":"Literature metadata","dateInSource":"2025-07-28","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-25062935-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-25062935-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-25062935-glatiramer-acetate-v1","contentSha256":"af3e87591b440fa27d5ce2f340f537f8446b657c7c6713c8546a1aea6a47c80d"},{"objectId":"story:pubmed-pmid-26445705-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Spasticity in multiple sclerosis and role of glatiramer acetate treatment.","domain":"Literature metadata","dateInSource":"2018-11-13","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-26445705-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-26445705-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-26445705-glatiramer-acetate-v1","contentSha256":"f08c8f658c5ceb8091e69c6c223a6d3fff1055166b6c97cd7210bcb1208942c0"},{"objectId":"story:pubmed-pmid-26458034-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial.","domain":"Literature metadata","dateInSource":"2022-03-30","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-26458034-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-26458034-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-26458034-glatiramer-acetate-v1","contentSha256":"5b630d2b257a2d91e15322287eee94896f03456002cd1915314acc1d310166a7"},{"objectId":"story:pubmed-pmid-26671082-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).","domain":"Literature metadata","dateInSource":"2015-12-16","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-26671082-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-26671082-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-26671082-glatiramer-acetate-v1","contentSha256":"caff6802424c89037db1a3d3864d740a2dd6a2d14ebd1e21a43d9cd2bb2c3768"},{"objectId":"story:pubmed-pmid-27363291-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Pharmacologic Treatment of Rett Syndrome With Glatiramer Acetate.","domain":"Literature metadata","dateInSource":"2018-05-15","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-27363291-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-27363291-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-27363291-glatiramer-acetate-v1","contentSha256":"d78eac26f8888c8a35807dd4d891873478b24360b0877e76ddf74204ff992deb"},{"objectId":"story:pubmed-pmid-27473139-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b.","domain":"Literature metadata","dateInSource":"2018-11-13","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-27473139-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-27473139-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-27473139-glatiramer-acetate-v1","contentSha256":"b65ec19be76f7e1498c8ddfa5a181581a8a6d802a85ff0f2e3e69adf5513a5b3"},{"objectId":"story:pubmed-pmid-27880972-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.","domain":"Literature metadata","dateInSource":"2026-09-06","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-27880972-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-27880972-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-27880972-glatiramer-acetate-v1","contentSha256":"9f598cd6bb998f51732330522c6f254b3db13be74d8da254acb5b60cb15e7f92"},{"objectId":"story:pubmed-pmid-29241378-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Equivalence of glatiramer acetate products: challenges in assessing pharmaceutical equivalence and critical clinical performance attributes.","domain":"Literature metadata","dateInSource":"2019-07-22","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29241378-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-29241378-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-29241378-glatiramer-acetate-v1","contentSha256":"968e7889c971b7eb6bd5c25681869d131aae4600d1c918cbe43e8cf001a12618"},{"objectId":"story:pubmed-pmid-30775037-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use.","domain":"Literature metadata","dateInSource":"2020-09-29","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-30775037-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-30775037-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-30775037-glatiramer-acetate-v1","contentSha256":"1533446bbc1f806306c841050238a199e41c663fe43c7494e4c9948f0d56960a"},{"objectId":"story:pubmed-pmid-30902653-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Glatiramer acetate: A complex drug beyond biologics.","domain":"Literature metadata","dateInSource":"2019-08-15","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-30902653-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-30902653-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-30902653-glatiramer-acetate-v1","contentSha256":"9cea753a035252ec8d4b428df404db9bd72c7b600a22d64cb0dbe7e9d50894e9"},{"objectId":"story:pubmed-pmid-30905097-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Glatiramer Acetate: from Bench to Bed and Back.","domain":"Literature metadata","dateInSource":"2019-04-01","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-30905097-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-30905097-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-30905097-glatiramer-acetate-v1","contentSha256":"9126257fb053616b064ca6d258c4df1bc72886e58a0b28c33a775039d4f6177f"},{"objectId":"story:pubmed-pmid-31526436-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Comparison of Copaxone® and Synthon's therapeutically equivalent glatiramer acetate.","domain":"Literature metadata","dateInSource":"2020-06-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-31526436-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-31526436-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-31526436-glatiramer-acetate-v1","contentSha256":"217f2c651f8691d3675922203797a229e9acf27c30204274a535a80e9d1b7215"},{"objectId":"story:pubmed-pmid-32897569-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Rituximab and glatiramer acetate in secondary progressive multiple sclerosis: A randomized clinical trial.","domain":"Literature metadata","dateInSource":"2021-01-19","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-32897569-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-32897569-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-32897569-glatiramer-acetate-v1","contentSha256":"89b456184b9de4a535d5511c5d18e868a511d7d9a84552df3b8d76574d07cfc1"},{"objectId":"story:pubmed-pmid-35493825-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Treatment Challenges in Multiple Sclerosis - A Continued Role for Glatiramer Acetate?","domain":"Literature metadata","dateInSource":"2022-07-16","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-35493825-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-35493825-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-35493825-glatiramer-acetate-v1","contentSha256":"206a9e9580806cd9e8e33df5cb58f0e94fa23cd22b0d2b540ed971ae55451373"},{"objectId":"story:pubmed-pmid-35563884-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation.","domain":"Literature metadata","dateInSource":"2025-06-23","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-35563884-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-35563884-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-35563884-glatiramer-acetate-v1","contentSha256":"6aec5a9e4031868d1acede9967f842153856c1cfec523ec10f23826b9dd2342e"},{"objectId":"story:pubmed-pmid-39406508-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"Glatiramer Acetate for the Treatment of Multiple Sclerosis: From First-Generation Therapy to Elucidation of Immunomodulation and Repair.","domain":"Literature metadata","dateInSource":"2026-05-21","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39406508-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-39406508-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-39406508-glatiramer-acetate-v1","contentSha256":"c767f4471681d78982de316c1ea4079aaf2de123ef1a724a201590cea83baac1"},{"objectId":"story:pubmed-pmid-41705515-glatiramer-acetate:v1","state":"current","stateChangedAt":"2026-11-16","title":"GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial.","domain":"Literature metadata","dateInSource":"2026-07-21","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41705515-glatiramer-acetate/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-41705515-glatiramer-acetate-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.md#pubmed-pmid-41705515-glatiramer-acetate-v1","contentSha256":"be4bf913ff33b146d8b3f9ca0613897db07afbbfd6813aea9ceae23d350ce8ab"}]}
